Latest On Biohaven Pharmaceutical Holding Company Ltd (BHVN):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-12 21:12 EST | News | Biohaven Non-GAAP EPS of -$0.98 | N/A |  |
| 2023-03-24 07:34 EST | News | Biohaven Non-GAAP EPS of -$1.27 beats by $0.01 | N/A | |
| 2023-03-22 08:38 EST | News | Biohaven acquires rights to potential brain disorder drug BHV-8000 for $10M upfront | N/A | |
| 2023-03-10 05:36 EST | News | Biohaven: Spun And Done - Time To Exit | N/A | |
| 2023-02-21 22:11 EST | News | Biohaven's spinal muscular atrophy therapy gets FDA fast track status | N/A | |
| 2023-01-04 17:02 EST | News | Biohaven initiated at overweight at JP Morgan on neurological targets | N/A | |
| 2022-12-08 04:49 EST | News | Biohaven Ltd: Assessing The Spinoff | N/A | |
| 2022-11-09 21:19 EST | News | Biohaven Non-GAAP EPS of -$1.25 | N/A | |
| 2022-10-21 04:41 EST | News | Biohaven prices upsized 25M of stock offering at $10.50/share | N/A | |
| 2022-10-18 16:23 EST | News | Biohaven stock falls 5% after the bell on 20M share offering | N/A | |
| 2022-10-07 13:52 EST | News | Biotech in recovery; but Piper Sandler cites negative fund flows | N/A | |
| 2022-10-07 13:49 EST | News | M&A may be a tailwind for biotech sector into end of year, analyst says | N/A | |
| 2022-10-07 13:40 EST | News | 'New' Biohaven up 81% days after Pfizer acquisition as investors see pipeline potential | N/A | |
| 2022-10-06 23:49 EST | News | Biohaven Stub May Provide An Interesting Setup For Investors | N/A | |
| 2022-09-29 23:19 EST | News | Biohaven says ALS candidate failed in key trial | N/A | |
| 2022-09-28 00:37 EST | News | Pfizer acquisition of Biohaven Pharmaceuticals expected to close Oct. 3 | N/A | |
| 2022-09-19 19:50 EST | News | Biohaven announces timeline for spinoff | N/A | |
| 2022-08-17 15:12 EST | News | Biohaven: Non-Standard Merger Consideration Makes This A Buy | N/A | |
| 2022-08-16 05:06 EST | News | Soros Fund Management takes new stakes in GCP, Biohaven, Tesla | N/A | |
| 2022-08-05 15:33 EST | News | Biohaven Pharmaceuticals Non-GAAP EPS of -$3.82 misses by $1.57, revenue of $194M misses by $16.6M | N/A | |
| 2022-07-07 09:59 EST | News | Biohaven begins enrolling in late-stage trial of spinal muscular atrophy therapy | N/A | |
| 2022-06-15 23:08 EST | News | Biohaven Deal: Pfizer Gives Away A Freeroll | N/A | |
| 2022-06-01 11:56 EST | News | Federal Trade Commission to hold pharma merger and antitrust workshop | N/A | |
| 2022-05-23 14:53 EST | News | Biohaven phase 3 trial in genetic muscle disorder fails to reach significance overall due to low disease progression | N/A | |
| 2022-05-23 14:53 EST | News | Biohaven gets FDA review for nasal spray zavegepant to treat migraine | N/A | |
| 2022-05-11 01:00 EST | News | Biohaven Pharmaceuticals Non-GAAP EPS of -$1.62 beats by $0.65, revenue of $318.85M beats by $135.14M | N/A | |
| 2022-05-11 01:00 EST | News | Pfizer to acquire Biohaven in ~$11.6B deal; Biohaven stock soars 72% | N/A | |
| 2022-05-06 21:00 EST | News | Biohaven Pharmaceuticals Q1 2022 Earnings Preview | N/A | |
| 2022-04-27 19:21 EST | News | Pfizer, Biohaven's Vydura gets approval in EU to prevent/treat migraine | N/A | |
| 2022-04-14 05:28 EST | News | Biohaven Pharmaceutical: Recent Growth Will Continue | N/A | |
| 2022-02-26 00:18 EST | News | Biohaven Pharmaceuticals Non-GAAP EPS of -$2.32 misses by $0.39, revenue of $190.01M beats by $14.47M | N/A | |
| 2022-02-26 00:18 EST | News | Biohaven in licensing pact with Bristol Myers; to acquire Channel Biosciences | N/A | |
| 2022-02-26 00:18 EST | News | Pfizer, Biohaven's rimegepant gets EMA panel nod for migraine treatment | N/A | |
| 2022-02-26 00:18 EST | News | Biohaven Pharmaceutical Holding Company Ltd. 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-02-26 00:17 EST | News | Biohaven Pharmaceutical Holding's (BHVN) CEO Vlad Coric on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-25 05:15 EST | News | Biohaven Pharmaceuticals Q4 2021 Earnings Preview | N/A | |
| 2022-02-22 19:32 EST | News | Biohaven begins enrollment in phase 2/3 trial of Nurtec ODT in chronic rhinosinusitis | N/A | |
| 2022-02-15 01:21 EST | News | Pfizer/ Biohaven announce late-stage migraine trial met main goals in Asia Pacific | N/A | |
| 2022-02-01 23:30 EST | News | New thematic psychedelic ETF hits the market | N/A | |
| 2022-01-28 21:24 EST | News | Aurinia Pharmaceuticals quick uptick on renewed takeover speculation on Biogen news | N/A | |
| 2022-01-18 18:11 EST | News | Biohaven’s Troriluzole to undergo glioblastoma trial designed to study multiple therapies | N/A | |
| 2022-01-14 05:01 EST | News | Aurinia Pharmaceuticals reverses decline after report on potential M&A interest | N/A | |
| 2022-01-10 16:33 EST | News | Biohaven forms research collaboration to advance TRPM3 antagonists for pain management | N/A | |
| 2022-01-06 09:41 EST | News | Biohaven reports preliminary Q4 Nurtec ODT revenue of $190M | N/A | |
| 2021-12-07 06:52 EST | News | Biohaven names Vlad Coric as Chairman, appoints new CFO | N/A | |
| 2021-12-06 12:13 EST | News | Biohaven says pivotal study for intranasal migraine therapy met main goals | N/A | |
| 2021-12-06 12:13 EST | News | Biohaven names new CEO, CFO | N/A | |
| 2021-11-18 11:13 EST | News | Biohaven, Artizan to work on Parkinson's drug discovery program | N/A | |
| 2021-11-17 13:22 EST | News | Biohaven's migraine med Nurtec approved in Kuwait | N/A | |
| 2021-11-10 03:44 EST | News | Pfizer to gain ex-U.S. rights to Biohaven migraine med Nurtec in up to $1.24B deal | N/A | |
About Biohaven Pharmaceutical Holding Company Ltd (BHVN):
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological diseases and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as id developing Rimegepant for preventive treatment of migraine and other non-migraine indications; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole, which is in phase III clinical trials for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 that is in phase I clinical trial for neuropsychiatric indications; and Verdiperstat, a product that is in phase III trial for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.
General
- Name Biohaven Pharmaceutical Holding Company Ltd
- Symbol BHVN
- Type Common Stock
- Exchange NYSE
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 825
- Fiscal Year EndDecember
- IPO Date2017-05-04
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.biohavenpharma.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 71.25
- Price/Book (Most Recent Quarter) 31.82
- Enterprise Value Revenue 73.75
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$10.49
- Next Year EPS Estimate -$5.57
- Next Quarter EPS Estimate -$2.73
- Operating Margin -1014%
- Return on Assets -78%
- Revenue 63.63 million
- Earnings Per Share -$9.14
- Revenue Per Share $1.08
- Gross Profit 45.93 million
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 4.42 billion
- EBITDA -356321504
- Analyst Target Price $102.09
- Book Value Per Share $2.09
View More
Share Statistics
- Shares Outstanding 61.93 million
- Shares Float 54.37 million
- % Held by Insiders 1379%
- % Held by Institutions 117.55%
- Shares Short 5.76 million
- Shares Short Prior Month 5.98 million
- Short Ratio 11.39
- Short % of Float 13%
- Short % of Shares Outstanding 9%
View More
Technicals
- Beta 1.08
- 52 Week High $100.77
- 52 Week Low $28.26
- 50 Day Moving Average 82.8
- 200 Day Moving Average 80.62
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Biohaven Pharmaceutical Holding Company Ltd (BHVN) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Biohaven Pharmaceutical Holding Company Ltd (BHVN) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-01 | $N/A | -$2.69 | -$2.56 | -4.98% |
| 2020-09-30 | 2020-11-09 | $17.66 million | -$2.67 | -$2.86 | 6.58% |
| 2020-06-30 | 2020-08-10 | $9.7 million | -$2.55 | -$2.84 | 10.27% |
| 2020-03-31 | 2020-05-07 | $1.15 million | -$2.39 | -$2.46 | 2.94% |
| 2019-12-31 | 2020-02-25 | $N/A | -$2.85 | -$1.91 | -49.31% |
| 2019-09-30 | 2019-11-01 | $N/A | -$2.04 | -$1.57 | -30.24% |
| 2019-06-30 | 2019-08-08 | $N/A | -$4.67 | -$2.09 | -123.21% |
| 2019-03-31 | 2019-05-07 | $N/A | -$1.41 | -$1.50 | 5.94% |
| 2018-12-31 | 2019-02-28 | $N/A | -$1.33 | -$1.21 | -10.12% |
| 2018-09-30 | 2018-11-14 | $N/A | -$1.53 | -$1.08 | -42.33% |
| 2018-06-30 | 2018-08-14 | $N/A | -$1.01 | -$1.05 | 3.68% |
| 2018-03-31 | 2018-05-15 | $N/A | -$2.32 | -$1.17 | -98.29% |
| 2017-12-31 | 2018-03-06 | $N/A | -$0.75 | -$1.35 | 44.34% |
| 2017-09-30 | 2017-11-14 | $N/A | -$1.19 | -$1.24 | 3.78% |
| 2017-06-30 | 2017-08-14 | $N/A | -$1.78 | -$0.62 | -185.94% |
| 2017-03-31 | 2017-06-16 | $N/A | -$1.74 | -$1.45 | -20% |
Biohaven Pharmaceutical Holding Company Ltd (BHVN) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Biohaven Pharmaceutical Holding Company Ltd (BHVN) Chart:
Biohaven Pharmaceutical Holding Company Ltd (BHVN) News:
Below you will find a list of latest news for Biohaven Pharmaceutical Holding Company Ltd (BHVN) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Biohaven Pharmaceutical Holding Company Ltd (BHVN) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-17 | 1 | 12.84 | CALL | 0 | 1 | 0 | TRUE | 0 | 0 |
| 2026-07-17 | 2.5 | 0 | CALL | 0 | 1 | 0 | TRUE | 0 | 0 |
| 2026-07-17 | 4 | 0 | CALL | 0 | 3 | 0 | TRUE | 0 | 0 |
| 2026-07-17 | 5 | 0 | CALL | 0 | 10 | 0 | TRUE | 0 | 0 |
| 2026-07-17 | 6 | 0 | CALL | 0 | 53 | 0 | TRUE | 0 | 0 |
| 2026-07-17 | 7.5 | 0 | CALL | 0 | 78 | 122.21 | TRUE | 0 | 0 |
| 2026-07-17 | 9 | 0 | CALL | 0 | 115 | 121.04 | TRUE | 0 | 0 |
| 2026-07-17 | 10 | 3.9 | CALL | 0 | 307 | 103.39 | TRUE | 0 | 0 |
| 2026-07-17 | 11 | 2.8 | CALL | 1045 | 4384 | 90.3 | TRUE | -0.2 | -0.07 |
| 2026-07-17 | 12.5 | 1.9 | CALL | 237 | 3026 | 92.59 | TRUE | 0.15 | 0.09 |
| 2026-07-17 | 14 | 1.3 | CALL | 48 | 893 | 89.8 | FALSE | 0.15 | 0.13 |
| 2026-07-17 | 15 | 0.78 | CALL | 120 | 5903 | 86.59 | FALSE | -0.19 | -0.2 |
| 2026-07-17 | 16 | 0.55 | CALL | 3 | 619 | 96.34 | FALSE | -0.1 | -0.15 |
| 2026-07-17 | 17.5 | 0.38 | CALL | 92 | 5154 | 91.97 | FALSE | -0.04 | -0.1 |
| 2026-07-17 | 19 | 0 | CALL | 0 | 48 | 104.35 | FALSE | 0 | 0 |
| 2026-07-17 | 20 | 0 | CALL | 0 | 727 | 132.29 | FALSE | 0 | 0 |
| 2026-07-17 | 21 | 0.14 | CALL | 1 | 275 | 132.22 | FALSE | 0.14 | 0 |
| 2026-07-17 | 22 | 0 | CALL | 0 | 0 | 204.54 | FALSE | 0 | 0 |
| 2026-07-17 | 23 | 0 | CALL | 0 | 0 | 214.13 | FALSE | 0 | 0 |
| 2026-07-17 | 24 | 0 | CALL | 0 | 0 | 221.15 | FALSE | 0 | 0 |
| 2026-07-17 | 25 | 0 | CALL | 0 | 0 | 229.56 | FALSE | 0 | 0 |
| 2026-07-17 | 26 | 0 | CALL | 0 | 0 | 237.48 | FALSE | 0 | 0 |
| 2026-07-17 | 1 | 0 | PUT | 0 | 1 | 439.92 | FALSE | 0 | 0 |
| 2026-07-17 | 2.5 | 0 | PUT | 0 | 0 | 534.12 | FALSE | 0 | 0 |
| 2026-07-17 | 4 | 0 | PUT | 0 | 0 | 386.2 | FALSE | 0 | 0 |
| 2026-07-17 | 5 | 0 | PUT | 0 | 2 | 298.8 | FALSE | 0 | 0 |
| 2026-07-17 | 6 | 0 | PUT | 0 | 6 | 251.13 | FALSE | 0 | 0 |
| 2026-07-17 | 7.5 | 0.1 | PUT | 2 | 156 | 118.67 | FALSE | 0.1 | 0 |
| 2026-07-17 | 9 | 0 | PUT | 0 | 141 | 146.63 | FALSE | 0 | 0 |
| 2026-07-17 | 10 | 0.18 | PUT | 6 | 506 | 124.69 | FALSE | 0 | 0 |
| 2026-07-17 | 11 | 0.35 | PUT | 17 | 5143 | 95.51 | FALSE | -0.05 | -0.13 |
| 2026-07-17 | 12.5 | 0.94 | PUT | 2 | 76 | 85.61 | FALSE | 0.01 | 0.01 |
| 2026-07-17 | 14 | 2.2 | PUT | 0 | 12 | 88.62 | TRUE | 0 | 0 |
| 2026-07-17 | 15 | 2.33 | PUT | 0 | 133 | 98.97 | TRUE | 0 | 0 |
| 2026-07-17 | 16 | 0 | PUT | 0 | 100 | 91.5 | TRUE | 0 | 0 |
| 2026-07-17 | 17.5 | 0 | PUT | 0 | 0 | 92.86 | TRUE | 0 | 0 |
| 2026-07-17 | 19 | 0 | PUT | 0 | 0 | 115.6 | TRUE | 0 | 0 |
| 2026-07-17 | 20 | 0 | PUT | 0 | 1 | 115.89 | TRUE | 0 | 0 |
| 2026-07-17 | 21 | 7.7 | PUT | 2 | 0 | 83.01 | TRUE | 7.7 | 0 |
| 2026-07-17 | 22 | 0 | PUT | 0 | 0 | 150.82 | TRUE | 0 | 0 |
| 2026-07-17 | 23 | 9.56 | PUT | 2 | 0 | 123 | TRUE | 9.56 | 0 |
| 2026-07-17 | 24 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-07-17 | 25 | 0 | PUT | 0 | 0 | 164.3 | TRUE | 0 | 0 |
| 2026-07-17 | 26 | 12.65 | PUT | 2 | 0 | 158.31 | TRUE | 12.65 | 0 |
| 2026-08-21 | 4 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-08-21 | 5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-08-21 | 6 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-08-21 | 7 | 0 | CALL | 0 | 0 | 97.83 | TRUE | 0 | 0 |
| 2026-08-21 | 8 | 0 | CALL | 0 | 0 | 96.35 | TRUE | 0 | 0 |
| 2026-08-21 | 9 | 0 | CALL | 0 | 0 | 103.57 | TRUE | 0 | 0 |
| 2026-08-21 | 10 | 0 | CALL | 0 | 0 | 100.3 | TRUE | 0 | 0 |
| 2026-08-21 | 11 | 0 | CALL | 0 | 0 | 103.57 | TRUE | 0 | 0 |
| 2026-08-21 | 12 | 2.87 | CALL | 129 | 0 | 86.75 | TRUE | 2.87 | 0 |
| 2026-08-21 | 13 | 0 | CALL | 0 | 0 | 64.58 | TRUE | 0 | 0 |
| 2026-08-21 | 14 | 0 | CALL | 0 | 0 | 71.68 | FALSE | 0 | 0 |
| 2026-08-21 | 15 | 0 | CALL | 0 | 0 | 108.71 | FALSE | 0 | 0 |
| 2026-08-21 | 16 | 0 | CALL | 0 | 0 | 115.58 | FALSE | 0 | 0 |
| 2026-08-21 | 17 | 0 | CALL | 0 | 0 | 83.56 | FALSE | 0 | 0 |
| 2026-08-21 | 18 | 0 | CALL | 0 | 0 | 126.46 | FALSE | 0 | 0 |
| 2026-08-21 | 19 | 0 | CALL | 0 | 0 | 132.29 | FALSE | 0 | 0 |
| 2026-08-21 | 20 | 0 | CALL | 0 | 0 | 137.2 | FALSE | 0 | 0 |
| 2026-08-21 | 4 | 0 | PUT | 0 | 0 | 356.32 | FALSE | 0 | 0 |
| 2026-08-21 | 5 | 0 | PUT | 0 | 0 | 296.16 | FALSE | 0 | 0 |
| 2026-08-21 | 6 | 0 | PUT | 0 | 0 | 250.21 | FALSE | 0 | 0 |
| 2026-08-21 | 7 | 0 | PUT | 0 | 0 | 217.39 | FALSE | 0 | 0 |
| 2026-08-21 | 8 | 0 | PUT | 0 | 0 | 189.17 | FALSE | 0 | 0 |
| 2026-08-21 | 9 | 0 | PUT | 0 | 0 | 167.56 | FALSE | 0 | 0 |
| 2026-08-21 | 10 | 0 | PUT | 0 | 0 | 148.91 | FALSE | 0 | 0 |
| 2026-08-21 | 11 | 0 | PUT | 0 | 0 | 134.98 | FALSE | 0 | 0 |
| 2026-08-21 | 12 | 0 | PUT | 0 | 0 | 120.47 | FALSE | 0 | 0 |
| 2026-08-21 | 13 | 0 | PUT | 0 | 0 | 66.86 | FALSE | 0 | 0 |
| 2026-08-21 | 14 | 0 | PUT | 0 | 0 | 98.45 | TRUE | 0 | 0 |
| 2026-08-21 | 15 | 0 | PUT | 0 | 0 | 97.99 | TRUE | 0 | 0 |
| 2026-08-21 | 16 | 0 | PUT | 0 | 0 | 98.24 | TRUE | 0 | 0 |
| 2026-08-21 | 17 | 0 | PUT | 0 | 0 | 99.62 | TRUE | 0 | 0 |
| 2026-08-21 | 18 | 0 | PUT | 0 | 0 | 101.46 | TRUE | 0 | 0 |
| 2026-08-21 | 19 | 0 | PUT | 0 | 0 | 105.5 | TRUE | 0 | 0 |
| 2026-08-21 | 20 | 0 | PUT | 0 | 0 | 102.9 | TRUE | 0 | 0 |
| 2026-10-16 | 3 | 0 | CALL | 0 | 1 | 0 | TRUE | 0 | 0 |
| 2026-10-16 | 4 | 0 | CALL | 0 | 0 | 105.11 | TRUE | 0 | 0 |
| 2026-10-16 | 5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-10-16 | 6 | 0 | CALL | 0 | 0 | 127.95 | TRUE | 0 | 0 |
| 2026-10-16 | 7 | 0 | CALL | 0 | 21 | 115.25 | TRUE | 0 | 0 |
| 2026-10-16 | 8 | 6.06 | CALL | 5 | 35 | 128.11 | TRUE | 6.06 | 0 |
| 2026-10-16 | 9 | 5.39 | CALL | 0 | 51 | 113.1 | TRUE | 0 | 0 |
| 2026-10-16 | 10 | 5.26 | CALL | 1 | 119 | 99.02 | TRUE | 0.5 | 0.11 |
| 2026-10-16 | 11 | 3.98 | CALL | 0 | 282 | 103.8 | TRUE | 0 | 0 |
| 2026-10-16 | 12 | 3.7 | CALL | 16 | 1013 | 98.06 | TRUE | -0.3 | -0.08 |
| 2026-10-16 | 13 | 2.99 | CALL | 0 | 123 | 98.91 | TRUE | 0 | 0 |
| 2026-10-16 | 14 | 3.5 | CALL | 101 | 42 | 79.78 | FALSE | 0.56 | 0.19 |
| 2026-10-16 | 15 | 2.48 | CALL | 1 | 465 | 91.41 | FALSE | 0.16 | 0.07 |
| 2026-10-16 | 16 | 1.78 | CALL | 0 | 38 | 97.3 | FALSE | 0 | 0 |
| 2026-10-16 | 17 | 2.2 | CALL | 0 | 11 | 92.22 | FALSE | 0 | 0 |
| 2026-10-16 | 18 | 1.8 | CALL | 0 | 67 | 93.29 | FALSE | 0 | 0 |
| 2026-10-16 | 19 | 0 | CALL | 0 | 47 | 102.64 | FALSE | 0 | 0 |
| 2026-10-16 | 20 | 0 | CALL | 0 | 1133 | 108.9 | FALSE | 0 | 0 |
| 2026-10-16 | 21 | 0 | CALL | 0 | 0 | 112.09 | FALSE | 0 | 0 |
| 2026-10-16 | 22 | 0 | CALL | 0 | 0 | 113.93 | FALSE | 0 | 0 |
| 2026-10-16 | 23 | 0 | CALL | 0 | 0 | 116.17 | FALSE | 0 | 0 |
| 2026-10-16 | 24 | 0 | CALL | 0 | 0 | 118.93 | FALSE | 0 | 0 |
| 2026-10-16 | 25 | 0 | CALL | 0 | 0 | 121.36 | FALSE | 0 | 0 |
| 2026-10-16 | 26 | 0 | CALL | 0 | 0 | 123.49 | FALSE | 0 | 0 |
| 2026-10-16 | 3 | 0 | PUT | 0 | 0 | 164.6 | FALSE | 0 | 0 |
| 2026-10-16 | 4 | 0 | PUT | 0 | 0 | 177.52 | FALSE | 0 | 0 |
| 2026-10-16 | 5 | 0 | PUT | 0 | 1 | 147.98 | FALSE | 0 | 0 |
| 2026-10-16 | 6 | 0.25 | PUT | 2 | 7 | 113.77 | FALSE | 0.25 | 0 |
| 2026-10-16 | 7 | 0 | PUT | 0 | 4 | 111.38 | FALSE | 0 | 0 |
| 2026-10-16 | 8 | 0 | PUT | 0 | 1 | 104.07 | FALSE | 0 | 0 |
| 2026-10-16 | 9 | 0 | PUT | 0 | 135 | 105.19 | FALSE | 0 | 0 |
| 2026-10-16 | 10 | 1.1 | PUT | 0 | 148 | 100.62 | FALSE | 0 | 0 |
| 2026-10-16 | 11 | 0 | PUT | 0 | 120 | 100.57 | FALSE | 0 | 0 |
| 2026-10-16 | 12 | 0 | PUT | 0 | 1 | 105.6 | FALSE | 0 | 0 |
| 2026-10-16 | 13 | 2.5 | PUT | 2 | 9 | 101.11 | FALSE | 2.5 | 0 |
| 2026-10-16 | 14 | 0 | PUT | 0 | 0 | 93.69 | TRUE | 0 | 0 |
| 2026-10-16 | 15 | 0 | PUT | 0 | 12 | 92.38 | TRUE | 0 | 0 |
| 2026-10-16 | 16 | 0 | PUT | 0 | 0 | 67.61 | TRUE | 0 | 0 |
| 2026-10-16 | 17 | 0 | PUT | 0 | 2 | 90.37 | TRUE | 0 | 0 |
| 2026-10-16 | 18 | 0 | PUT | 0 | 0 | 111.34 | TRUE | 0 | 0 |
| 2026-10-16 | 19 | 0 | PUT | 0 | 0 | 90.06 | TRUE | 0 | 0 |
| 2026-10-16 | 20 | 0 | PUT | 0 | 0 | 89.19 | TRUE | 0 | 0 |
| 2026-10-16 | 21 | 0 | PUT | 0 | 0 | 100.45 | TRUE | 0 | 0 |
| 2026-10-16 | 22 | 0 | PUT | 0 | 0 | 90.44 | TRUE | 0 | 0 |
| 2026-10-16 | 23 | 0 | PUT | 0 | 0 | 91.02 | TRUE | 0 | 0 |
| 2026-10-16 | 24 | 0 | PUT | 0 | 0 | 90.96 | TRUE | 0 | 0 |
| 2026-10-16 | 25 | 0 | PUT | 0 | 0 | 87.45 | TRUE | 0 | 0 |
| 2026-10-16 | 26 | 0 | PUT | 0 | 0 | 88.42 | TRUE | 0 | 0 |
| 2026-12-18 | 2.5 | 0 | CALL | 0 | 35 | 0 | TRUE | 0 | 0 |
| 2026-12-18 | 5 | 0 | CALL | 0 | 30 | 155.46 | TRUE | 0 | 0 |
| 2026-12-18 | 6 | 0 | CALL | 0 | 0 | 116.4 | TRUE | 0 | 0 |
| 2026-12-18 | 7.5 | 7.06 | CALL | 0 | 87 | 118.75 | TRUE | 0 | 0 |
| 2026-12-18 | 9 | 0 | CALL | 0 | 15 | 118.75 | TRUE | 0 | 0 |
| 2026-12-18 | 10 | 6 | CALL | 0 | 264 | 120.59 | TRUE | 0 | 0 |
| 2026-12-18 | 11 | 5 | CALL | 0 | 6 | 115.62 | TRUE | 0 | 0 |
| 2026-12-18 | 12.5 | 4.8 | CALL | 0 | 146 | 116.04 | TRUE | 0 | 0 |
| 2026-12-18 | 14 | 0 | CALL | 0 | 0 | 116.9 | FALSE | 0 | 0 |
| 2026-12-18 | 15 | 3.85 | CALL | 0 | 494 | 110.42 | FALSE | 0 | 0 |
| 2026-12-18 | 16 | 3.5 | CALL | 0 | 10 | 116.85 | FALSE | 0 | 0 |
| 2026-12-18 | 17.5 | 3.04 | CALL | 0 | 49 | 113.1 | FALSE | 0 | 0 |
| 2026-12-18 | 20 | 0 | CALL | 0 | 672 | 129.02 | FALSE | 0 | 0 |
| 2026-12-18 | 22.5 | 0 | CALL | 0 | 32 | 105.4 | FALSE | 0 | 0 |
| 2026-12-18 | 25 | 0 | CALL | 0 | 45 | 114.76 | FALSE | 0 | 0 |
| 2026-12-18 | 27.5 | 0 | CALL | 0 | 0 | 112.17 | FALSE | 0 | 0 |
| 2026-12-18 | 30 | 0 | CALL | 0 | 6 | 122.75 | FALSE | 0 | 0 |
| 2026-12-18 | 32.5 | 0.9 | CALL | 0 | 1 | 97.84 | FALSE | 0 | 0 |
| 2026-12-18 | 35 | 0.94 | CALL | 0 | 62 | 102.99 | FALSE | 0 | 0 |
| 2026-12-18 | 37.5 | 0 | CALL | 0 | 0 | 120.59 | FALSE | 0 | 0 |
| 2026-12-18 | 40 | 0 | CALL | 0 | 4 | 122.41 | FALSE | 0 | 0 |
| 2026-12-18 | 42.5 | 0 | CALL | 0 | 1 | 104.64 | FALSE | 0 | 0 |
| 2026-12-18 | 45 | 0.5 | CALL | 2 | 37 | 108.17 | FALSE | 0.5 | 0 |
| 2026-12-18 | 47.5 | 0 | CALL | 0 | 2 | 108.8 | FALSE | 0 | 0 |
| 2026-12-18 | 50 | 0 | CALL | 0 | 11 | 110.45 | FALSE | 0 | 0 |
| 2026-12-18 | 52.5 | 0 | CALL | 0 | 9 | 113.3 | FALSE | 0 | 0 |
| 2026-12-18 | 55 | 0 | CALL | 0 | 2 | 114.5 | FALSE | 0 | 0 |
| 2026-12-18 | 57.5 | 0 | CALL | 0 | 0 | 122.76 | FALSE | 0 | 0 |
| 2026-12-18 | 60 | 0 | CALL | 0 | 15 | 154.1 | FALSE | 0 | 0 |
| 2026-12-18 | 65 | 0 | CALL | 0 | 38 | 123.89 | FALSE | 0 | 0 |
| 2026-12-18 | 2.5 | 0 | PUT | 0 | 65 | 142.97 | FALSE | 0 | 0 |
| 2026-12-18 | 5 | 0 | PUT | 0 | 3 | 120.49 | FALSE | 0 | 0 |
| 2026-12-18 | 6 | 0 | PUT | 0 | 0 | 114.96 | FALSE | 0 | 0 |
| 2026-12-18 | 7.5 | 0 | PUT | 0 | 222 | 112.68 | FALSE | 0 | 0 |
| 2026-12-18 | 9 | 1.61 | PUT | 2 | 102 | 112.91 | FALSE | 1.61 | 0 |
| 2026-12-18 | 10 | 0 | PUT | 0 | 276 | 112.34 | FALSE | 0 | 0 |
| 2026-12-18 | 11 | 0 | PUT | 0 | 1 | 111.88 | FALSE | 0 | 0 |
| 2026-12-18 | 12.5 | 3.4 | PUT | 9 | 309 | 129.15 | FALSE | 0 | 0 |
| 2026-12-18 | 14 | 4.21 | PUT | 0 | 6 | 112.79 | TRUE | 0 | 0 |
| 2026-12-18 | 15 | 5.1 | PUT | 1 | 199 | 109.54 | TRUE | 0.4 | 0.09 |
| 2026-12-18 | 16 | 0 | PUT | 0 | 0 | 109.64 | TRUE | 0 | 0 |
| 2026-12-18 | 17.5 | 0 | PUT | 0 | 54 | 125.57 | TRUE | 0 | 0 |
| 2026-12-18 | 20 | 0 | PUT | 0 | 100 | 121.88 | TRUE | 0 | 0 |
| 2026-12-18 | 22.5 | 0 | PUT | 0 | 22 | 123.43 | TRUE | 0 | 0 |
| 2026-12-18 | 25 | 0 | PUT | 0 | 8 | 108.95 | TRUE | 0 | 0 |
| 2026-12-18 | 27.5 | 0 | PUT | 0 | 0 | 119.06 | TRUE | 0 | 0 |
| 2026-12-18 | 30 | 0 | PUT | 0 | 330 | 119.3 | TRUE | 0 | 0 |
| 2026-12-18 | 32.5 | 0 | PUT | 0 | 0 | 107.68 | TRUE | 0 | 0 |
| 2026-12-18 | 35 | 0 | PUT | 0 | 0 | 101.12 | TRUE | 0 | 0 |
| 2026-12-18 | 37.5 | 0 | PUT | 0 | 0 | 98.25 | TRUE | 0 | 0 |
| 2026-12-18 | 40 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-12-18 | 42.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-12-18 | 45 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-12-18 | 47.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2026-12-18 | 50 | 0 | PUT | 0 | 0 | 122.86 | TRUE | 0 | 0 |
| 2026-12-18 | 52.5 | 0 | PUT | 0 | 0 | 109.04 | TRUE | 0 | 0 |
| 2026-12-18 | 55 | 0 | PUT | 0 | 0 | 129.99 | TRUE | 0 | 0 |
| 2026-12-18 | 57.5 | 0 | PUT | 0 | 0 | 133.32 | TRUE | 0 | 0 |
| 2026-12-18 | 60 | 0 | PUT | 0 | 0 | 136.52 | TRUE | 0 | 0 |
| 2026-12-18 | 65 | 0 | PUT | 0 | 0 | 124.4 | TRUE | 0 | 0 |
| 2027-01-15 | 1 | 0 | CALL | 0 | 0 | 215.97 | TRUE | 0 | 0 |
| 2027-01-15 | 2.5 | 0 | CALL | 0 | 55 | 0 | TRUE | 0 | 0 |
| 2027-01-15 | 4 | 0 | CALL | 0 | 0 | 125.8 | TRUE | 0 | 0 |
| 2027-01-15 | 5 | 8.95 | CALL | 0 | 70 | 121.02 | TRUE | 0 | 0 |
| 2027-01-15 | 6 | 0 | CALL | 0 | 0 | 120.53 | TRUE | 0 | 0 |
| 2027-01-15 | 7.5 | 7.45 | CALL | 0 | 76 | 114.66 | TRUE | 0 | 0 |
| 2027-01-15 | 9 | 0 | CALL | 0 | 17 | 132.57 | TRUE | 0 | 0 |
| 2027-01-15 | 10 | 5.95 | CALL | 0 | 719 | 120.29 | TRUE | 0 | 0 |
| 2027-01-15 | 11 | 5.5 | CALL | 0 | 4 | 118.1 | TRUE | 0 | 0 |
| 2027-01-15 | 12.5 | 5.7 | CALL | 20 | 1215 | 129.07 | TRUE | 0.6 | 0.12 |
| 2027-01-15 | 14 | 4.25 | CALL | 0 | 8 | 113.8 | FALSE | 0 | 0 |
| 2027-01-15 | 15 | 4.5 | CALL | 1 | 4973 | 108.86 | FALSE | 0.3 | 0.07 |
| 2027-01-15 | 16 | 3.5 | CALL | 30 | 82 | 107.25 | FALSE | -0.11 | -0.03 |
| 2027-01-15 | 17.5 | 3.5 | CALL | 0 | 126 | 111.77 | FALSE | 0 | 0 |
| 2027-01-15 | 20 | 2.9 | CALL | 0 | 106 | 108.94 | FALSE | 0 | 0 |
| 2027-01-15 | 22.5 | 0 | CALL | 0 | 3 | 112.81 | FALSE | 0 | 0 |
| 2027-01-15 | 25 | 0 | CALL | 0 | 100 | 96.19 | FALSE | 0 | 0 |
| 2027-01-15 | 27.5 | 0 | CALL | 0 | 332 | 88.5 | FALSE | 0 | 0 |
| 2027-01-15 | 30 | 1.25 | CALL | 0 | 3949 | 102.96 | FALSE | 0 | 0 |
| 2027-01-15 | 32.5 | 0 | CALL | 0 | 8 | 100.21 | FALSE | 0 | 0 |
| 2027-01-15 | 35 | 0 | CALL | 0 | 5 | 99.3 | FALSE | 0 | 0 |
| 2027-01-15 | 37.5 | 0 | CALL | 0 | 0 | 112.11 | FALSE | 0 | 0 |
| 2027-01-15 | 40 | 0 | CALL | 0 | 106 | 107.79 | FALSE | 0 | 0 |
| 2027-01-15 | 42.5 | 0 | CALL | 0 | 50 | 101.74 | FALSE | 0 | 0 |
| 2027-01-15 | 45 | 0.6 | CALL | 2 | 8 | 99.37 | FALSE | 0.6 | 0 |
| 2027-01-15 | 47.5 | 0 | CALL | 0 | 0 | 101.17 | FALSE | 0 | 0 |
| 2027-01-15 | 50 | 0 | CALL | 0 | 11 | 104.01 | FALSE | 0 | 0 |
| 2027-01-15 | 52.5 | 0 | CALL | 0 | 0 | 110.42 | FALSE | 0 | 0 |
| 2027-01-15 | 55 | 0 | CALL | 0 | 1 | 107.86 | FALSE | 0 | 0 |
| 2027-01-15 | 57.5 | 0 | CALL | 0 | 51 | 108.83 | FALSE | 0 | 0 |
| 2027-01-15 | 60 | 0 | CALL | 0 | 8 | 111.07 | FALSE | 0 | 0 |
| 2027-01-15 | 65 | 0 | CALL | 0 | 11 | 115.23 | FALSE | 0 | 0 |
| 2027-01-15 | 1 | 0 | PUT | 0 | 0 | 184.38 | FALSE | 0 | 0 |
| 2027-01-15 | 2.5 | 0 | PUT | 0 | 24 | 133.36 | FALSE | 0 | 0 |
| 2027-01-15 | 4 | 0 | PUT | 0 | 4 | 134.78 | FALSE | 0 | 0 |
| 2027-01-15 | 5 | 0.4 | PUT | 4 | 109 | 112.47 | FALSE | 0.4 | 0 |
| 2027-01-15 | 6 | 0 | PUT | 0 | 40 | 109.02 | FALSE | 0 | 0 |
| 2027-01-15 | 7.5 | 1.15 | PUT | 0 | 73 | 102.86 | FALSE | 0 | 0 |
| 2027-01-15 | 9 | 0 | PUT | 0 | 16 | 114.9 | FALSE | 0 | 0 |
| 2027-01-15 | 10 | 0 | PUT | 0 | 183 | 126.06 | FALSE | 0 | 0 |
| 2027-01-15 | 11 | 0 | PUT | 0 | 2 | 110.78 | FALSE | 0 | 0 |
| 2027-01-15 | 12.5 | 3.42 | PUT | 0 | 104 | 108.1 | FALSE | 0 | 0 |
| 2027-01-15 | 14 | 0 | PUT | 0 | 1 | 105.6 | TRUE | 0 | 0 |
| 2027-01-15 | 15 | 0 | PUT | 0 | 330 | 127.08 | TRUE | 0 | 0 |
| 2027-01-15 | 16 | 0 | PUT | 0 | 0 | 106.46 | TRUE | 0 | 0 |
| 2027-01-15 | 17.5 | 0 | PUT | 0 | 12 | 106.58 | TRUE | 0 | 0 |
| 2027-01-15 | 20 | 0 | PUT | 0 | 114 | 116.75 | TRUE | 0 | 0 |
| 2027-01-15 | 22.5 | 0 | PUT | 0 | 3 | 103.42 | TRUE | 0 | 0 |
| 2027-01-15 | 25 | 0 | PUT | 0 | 8 | 101.16 | TRUE | 0 | 0 |
| 2027-01-15 | 27.5 | 0 | PUT | 0 | 0 | 98.02 | TRUE | 0 | 0 |
| 2027-01-15 | 30 | 0 | PUT | 0 | 4 | 100.4 | TRUE | 0 | 0 |
| 2027-01-15 | 32.5 | 0 | PUT | 0 | 0 | 106.71 | TRUE | 0 | 0 |
| 2027-01-15 | 35 | 0 | PUT | 0 | 0 | 99.99 | TRUE | 0 | 0 |
| 2027-01-15 | 37.5 | 0 | PUT | 0 | 0 | 100.89 | TRUE | 0 | 0 |
| 2027-01-15 | 40 | 0 | PUT | 0 | 0 | 97.97 | TRUE | 0 | 0 |
| 2027-01-15 | 42.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2027-01-15 | 45 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2027-01-15 | 47.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2027-01-15 | 50 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2027-01-15 | 52.5 | 0 | PUT | 0 | 0 | 120.16 | TRUE | 0 | 0 |
| 2027-01-15 | 55 | 0 | PUT | 0 | 0 | 120.43 | TRUE | 0 | 0 |
| 2027-01-15 | 57.5 | 0 | PUT | 0 | 0 | 126.58 | TRUE | 0 | 0 |
| 2027-01-15 | 60 | 0 | PUT | 0 | 0 | 129.58 | TRUE | 0 | 0 |
| 2027-01-15 | 65 | 0 | PUT | 0 | 0 | 135.23 | TRUE | 0 | 0 |
| 2028-01-21 | 2.5 | 11.53 | CALL | 0 | 485 | 0 | TRUE | 0 | 0 |
| 2028-01-21 | 5 | 0 | CALL | 0 | 123 | 105.45 | TRUE | 0 | 0 |
| 2028-01-21 | 7.5 | 9.18 | CALL | 0 | 493 | 109.62 | TRUE | 0 | 0 |
| 2028-01-21 | 10 | 8 | CALL | 0 | 1970 | 99.93 | TRUE | 0 | 0 |
| 2028-01-21 | 12.5 | 6.59 | CALL | 2 | 99 | 92.94 | TRUE | 0.09 | 0.01 |
| 2028-01-21 | 15 | 6.33 | CALL | 1 | 1318 | 100.54 | FALSE | 0.13 | 0.02 |
| 2028-01-21 | 17.5 | 0 | CALL | 0 | 17 | 100.53 | FALSE | 0 | 0 |
| 2028-01-21 | 20 | 5.18 | CALL | 20 | 1413 | 99.29 | FALSE | 0.48 | 0.1 |
| 2028-01-21 | 22.5 | 0 | CALL | 0 | 6 | 92.69 | FALSE | 0 | 0 |
| 2028-01-21 | 25 | 0 | CALL | 0 | 55 | 95.15 | FALSE | 0 | 0 |
| 2028-01-21 | 27.5 | 0 | CALL | 0 | 28 | 90.32 | FALSE | 0 | 0 |
| 2028-01-21 | 30 | 0 | CALL | 0 | 1023 | 87.13 | FALSE | 0 | 0 |
| 2028-01-21 | 32.5 | 0 | CALL | 0 | 0 | 83.34 | FALSE | 0 | 0 |
| 2028-01-21 | 35 | 0 | CALL | 0 | 135 | 86.62 | FALSE | 0 | 0 |
| 2028-01-21 | 2.5 | 0 | PUT | 0 | 11 | 101.5 | FALSE | 0 | 0 |
| 2028-01-21 | 5 | 1.35 | PUT | 0 | 2 | 104.47 | FALSE | 0 | 0 |
| 2028-01-21 | 7.5 | 0 | PUT | 0 | 8 | 114.66 | FALSE | 0 | 0 |
| 2028-01-21 | 10 | 4 | PUT | 0 | 825 | 96.64 | FALSE | 0 | 0 |
| 2028-01-21 | 12.5 | 0 | PUT | 0 | 22 | 101.72 | FALSE | 0 | 0 |
| 2028-01-21 | 15 | 0 | PUT | 0 | 14 | 99.04 | TRUE | 0 | 0 |
| 2028-01-21 | 17.5 | 0 | PUT | 0 | 1 | 95.01 | TRUE | 0 | 0 |
| 2028-01-21 | 20 | 0 | PUT | 0 | 1 | 90.75 | TRUE | 0 | 0 |
| 2028-01-21 | 22.5 | 0 | PUT | 0 | 0 | 96.08 | TRUE | 0 | 0 |
| 2028-01-21 | 25 | 0 | PUT | 0 | 0 | 87.64 | TRUE | 0 | 0 |
| 2028-01-21 | 27.5 | 0 | PUT | 0 | 0 | 85.77 | TRUE | 0 | 0 |
| 2028-01-21 | 30 | 0 | PUT | 0 | 1 | 90.9 | TRUE | 0 | 0 |
| 2028-01-21 | 32.5 | 0 | PUT | 0 | 0 | 87.71 | TRUE | 0 | 0 |
| 2028-01-21 | 35 | 0 | PUT | 0 | 24 | 83.44 | TRUE | 0 | 0 |
Latest BHVN Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 40 | $143.84 |
| Jun 13, 2022 7:59 PM EST | 9 | $143.84 |
| Jun 13, 2022 7:59 PM EST | 8 | $143.87 |
| Jun 13, 2022 7:59 PM EST | 100 | $143.87 |
| Jun 13, 2022 7:59 PM EST | 3 | $143.83 |
Biohaven Pharmaceutical Holding Company Ltd (BHVN) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm |
| 2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1689813/000021545719006904/0000215457-19-006904-index.htm |
| 2019-07-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1689813/000021545719008296/0000215457-19-008296-index.htm |
| 2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1689813/000083423720008248/0000834237-20-008248-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1689813/000083423720009073/0000834237-20-009073-index.htm |
| 2018-12-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000110465918071968/0001104659-18-071968-index.htm |
| 2019-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000110465919015412/0001104659-19-015412-index.htm |
| 2019-04-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000110465919020231/0001104659-19-020231-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000110465919027408/0001104659-19-027408-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000110465919027610/0001104659-19-027610-index.htm |
| 2019-08-19 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000110465919046550/0001104659-19-046550-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000110465920003210/0001104659-20-003210-index.htm |
| 2020-01-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000110465920009364/0001104659-20-009364-index.htm |
| 2020-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000110465920027268/0001104659-20-027268-index.htm |
| 2020-03-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000110465920041258/0001104659-20-041258-index.htm |
| 2020-04-16 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1689813/000110465920047706/0001104659-20-047706-index.htm |
| 2020-04-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000110465920047741/0001104659-20-047741-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1689813/000114420419008285/0001144204-19-008285-index.htm |
| 2018-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919118061265/0001209191-18-061265-index.htm |
| 2019-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm |
| 2019-02-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm |
| 2019-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119010164/0001209191-19-010164-index.htm |
| 2019-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119010166/0001209191-19-010166-index.htm |
| 2019-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119010174/0001209191-19-010174-index.htm |
| 2019-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119010177/0001209191-19-010177-index.htm |
| 2019-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119010184/0001209191-19-010184-index.htm |
| 2019-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119010209/0001209191-19-010209-index.htm |
| 2019-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119010214/0001209191-19-010214-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm |
| 2019-02-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm |
| 2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm |
| 2019-03-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm |
| 2019-03-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm |
| 2019-03-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm |
| 2019-04-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119023434/0001209191-19-023434-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119023435/0001209191-19-023435-index.htm |
| 2019-04-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119023859/0001209191-19-023859-index.htm |
| 2019-04-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119023860/0001209191-19-023860-index.htm |
| 2019-04-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119032463/0001209191-19-032463-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119032465/0001209191-19-032465-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119032466/0001209191-19-032466-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119032468/0001209191-19-032468-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119032470/0001209191-19-032470-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119032472/0001209191-19-032472-index.htm |
| 2019-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119039192/0001209191-19-039192-index.htm |
| 2019-06-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119039193/0001209191-19-039193-index.htm |
| 2019-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119039411/0001209191-19-039411-index.htm |
| 2019-06-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119039412/0001209191-19-039412-index.htm |
| 2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119039783/0001209191-19-039783-index.htm |
| 2019-07-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000120919119039785/0001209191-19-039785-index.htm |
| 2019-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1689813/000127417319000086/0001274173-19-000086-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1689813/000127417320000063/0001274173-20-000063-index.htm |
| 2019-09-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000141057819001022/0001410578-19-001022-index.htm |
| 2019-10-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000141057819001524/0001410578-19-001524-index.htm |
| 2019-12-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm |
| 2019-12-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218019006297/0001562180-19-006297-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020000346/0001562180-20-000346-index.htm |
| 2020-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm |
| 2020-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm |
| 2020-01-31 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020000722/0001562180-20-000722-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020000723/0001562180-20-000723-index.htm |
| 2020-03-12 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020002440/0001562180-20-002440-index.htm |
| 2020-04-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020003254/0001562180-20-003254-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020003255/0001562180-20-003255-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020003256/0001562180-20-003256-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020003257/0001562180-20-003257-index.htm |
| 2020-05-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020003258/0001562180-20-003258-index.htm |
| 2020-06-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm |
| 2020-06-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm |
| 2020-06-12 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004469/0001562180-20-004469-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004470/0001562180-20-004470-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm |
| 2020-06-12 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004473/0001562180-20-004473-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004603/0001562180-20-004603-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm |
| 2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm |
| 2020-06-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm |
| 2020-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm |
| 2020-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm |
| 2020-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020005986/0001562180-20-005986-index.htm |
| 2020-09-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006075/0001562180-20-006075-index.htm |
| 2020-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm |
| 2020-10-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006368/0001562180-20-006368-index.htm |
| 2020-10-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm |
| 2020-10-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm |
| 2020-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm |
| 2020-02-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1689813/000156223020000002/0001562230-20-000002-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1689813/000156223020000003/0001562230-20-000003-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1689813/000161577419002508/0001615774-19-002508-index.htm |
| 2018-12-10 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1689813/000162828018014980/0001628280-18-014980-index.htm |
| 2018-12-10 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1689813/000162828018014982/0001628280-18-014982-index.htm |
| 2018-12-10 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1689813/000162828018014985/0001628280-18-014985-index.htm |
| 2018-12-12 | S-1MEF | Registration adding securities to prior Form S-1 registration [Rule 462(b)] | https://www.sec.gov/Archives/edgar/data/1689813/000162828018015071/0001628280-18-015071-index.htm |
| 2018-12-14 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1689813/000162828018015109/0001628280-18-015109-index.htm |
| 2019-06-17 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1689813/000162828019008046/0001628280-19-008046-index.htm |
| 2019-06-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1689813/000162828019008061/0001628280-19-008061-index.htm |
| 2019-06-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1689813/000162828019008196/0001628280-19-008196-index.htm |
| 2019-06-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000162828019008232/0001628280-19-008232-index.htm |
| 2020-01-28 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1689813/000162828020000632/0001628280-20-000632-index.htm |
| 2020-01-30 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1689813/000162828020000742/0001628280-20-000742-index.htm |
| 2020-01-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000162828020000788/0001628280-20-000788-index.htm |
| 2018-12-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000168981318000042/0001689813-18-000042-index.htm |
| 2018-12-21 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1689813/000168981318000047/0001689813-18-000047-index.htm |
| 2018-12-21 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1689813/000168981318000049/0001689813-18-000049-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000010/0001689813-19-000010-index.htm |
| 2019-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000014/0001689813-19-000014-index.htm |
| 2019-04-11 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000020/0001689813-19-000020-index.htm |
| 2019-04-11 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000022/0001689813-19-000022-index.htm |
| 2019-05-01 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000026/0001689813-19-000026-index.htm |
| 2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000030/0001689813-19-000030-index.htm |
| 2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000034/0001689813-19-000034-index.htm |
| 2019-05-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000044/0001689813-19-000044-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000046/0001689813-19-000046-index.htm |
| 2019-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000052/0001689813-19-000052-index.htm |
| 2019-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000055/0001689813-19-000055-index.htm |
| 2019-08-09 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000056/0001689813-19-000056-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000061/0001689813-19-000061-index.htm |
| 2019-09-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm |
| 2019-09-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000066/0001689813-19-000066-index.htm |
| 2019-10-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm |
| 2019-10-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm |
| 2019-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000088/0001689813-19-000088-index.htm |
| 2019-11-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000089/0001689813-19-000089-index.htm |
| 2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm |
| 2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm |
| 2019-11-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm |
| 2019-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000106/0001689813-19-000106-index.htm |
| 2019-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000107/0001689813-19-000107-index.htm |
| 2019-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000108/0001689813-19-000108-index.htm |
| 2019-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000109/0001689813-19-000109-index.htm |
| 2019-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000110/0001689813-19-000110-index.htm |
| 2019-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000111/0001689813-19-000111-index.htm |
| 2019-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000112/0001689813-19-000112-index.htm |
| 2019-11-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000113/0001689813-19-000113-index.htm |
| 2019-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm |
| 2019-12-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm |
| 2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000128/0001689813-19-000128-index.htm |
| 2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000129/0001689813-19-000129-index.htm |
| 2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000130/0001689813-19-000130-index.htm |
| 2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000131/0001689813-19-000131-index.htm |
| 2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000132/0001689813-19-000132-index.htm |
| 2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000133/0001689813-19-000133-index.htm |
| 2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000134/0001689813-19-000134-index.htm |
| 2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000135/0001689813-19-000135-index.htm |
| 2019-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000136/0001689813-19-000136-index.htm |
| 2020-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000168981320000014/0001689813-20-000014-index.htm |
| 2020-02-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1689813/000168981320000016/0001689813-20-000016-index.htm |
| 2020-03-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000168981320000022/0001689813-20-000022-index.htm |
| 2020-03-20 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1689813/000168981320000027/0001689813-20-000027-index.htm |
| 2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000168981320000030/0001689813-20-000030-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000168981320000040/0001689813-20-000040-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1689813/000168981320000042/0001689813-20-000042-index.htm |
| 2020-05-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000168981320000044/0001689813-20-000044-index.htm |
| 2020-06-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000168981320000046/0001689813-20-000046-index.htm |
| 2020-06-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000168981320000049/0001689813-20-000049-index.htm |
| 2020-08-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000168981320000053/0001689813-20-000053-index.htm |
| 2020-08-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1689813/000168981320000057/0001689813-20-000057-index.htm |
| 2020-08-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1689813/000168981320000063/0001689813-20-000063-index.htm |
| 2018-12-12 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1689813/999999999518003115/9999999995-18-003115-index.htm |
Biohaven Pharmaceutical Holding Company Ltd (BHVN) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biohaven Pharmaceutical Holding Company Ltd (BHVN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 1379%Institutional Ownership: 11755%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-10-15 | Elyse Stock | Chief Medical Officer | Sell | 800.00 | 45.01 | 36,008.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm |
| 2019-10-18 | Elyse Stock | Chief Medical Officer | Sell | 17,700.00 | 45.07 | 797,749.62 | 0.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm |
| 2019-02-04 | ERIC AGUIAR | Director | Sell | 17,609.00 | 42.54 | 749,086.86 | 0.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm |
| 2019-09-11 | ERIC AGUIAR | Director | Sell | 10,000.00 | 45.00 | 450,000.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm |
| 2019-11-20 | ERIC AGUIAR | Director | Sell | 6,729.00 | 52.20 | 351,234.29 | 0.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm |
| 2019-11-22 | ERIC AGUIAR | Director | Sell | 1,250.00 | 55.24 | 69,050.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm |
| 2019-12-09 | ERIC AGUIAR | Director | Sell | 4,072.00 | 55.11 | 224,410.77 | 0.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm |
| 2019-12-16 | ERIC AGUIAR | Director | Sell | 3,537.00 | 55.13 | 194,984.55 | 0.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm |
| 2019-01-10 | John Tilton | Chief Commercial Officer | Sell | 10,500.00 | 37.67 | 395,535.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm |
| 2019-03-12 | John Tilton | Chief Commercial Officer | Sell | 10,000.00 | 50.11 | 501,100.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm |
| 2019-02-21 | JULIA P GREGORY | Director | Sell | 12,000.00 | 43.56 | 522,720.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm |
| 2019-11-22 | JULIA P GREGORY | Director | Sell | 12,000.00 | 54.75 | 656,956.80 | 0.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm |
| 2019-11-20 | Kimberly Gentile | SVP, Clinical Operations | Sell | 3,935.00 | 53.03 | 208,665.18 | 0.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm |
| 2019-11-21 | Kimberly Gentile | SVP, Clinical Operations | Sell | 21,065.00 | 53.04 | 1,117,205.45 | 0.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm |
| 2020-01-09 | ERIC AGUIAR | Director | Sell | 30,000.00 | 56.39 | 1,691,700.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm |
| 2019-02-04 | ERIC AGUIAR | Director | Buy | 10,000.00 | 25.51 | 255,100.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm |
| 2019-09-11 | ERIC AGUIAR | Director | Buy | 10,000.00 | 25.51 | 255,100.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm |
| 2019-03-12 | John Tilton | Chief Commercial Officer | Buy | 10,000.00 | 9.29 | 92,900.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm |
| 2019-06-26 | JOHN W CHILDS | Director | Buy | 10,000.00 | 40.37 | 403,700.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119039192/0001209191-19-039192-index.htm |
| 2019-03-26 | Declan Doogan | Director | Sell | 5,824.00 | 53.72 | 312,865.28 | 1,014,827.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm |
| 2019-03-22 | Declan Doogan | Director | Sell | 5,351.00 | 53.66 | 287,134.66 | 1,020,651.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm |
| 2019-03-01 | Declan Doogan | Director | Sell | 50,000.00 | 47.19 | 2,359,500.00 | 1,026,002.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm |
| 2019-01-10 | John Tilton | Chief Commercial Officer | Buy | 10,500.00 | 9.29 | 97,545.00 | 10,500.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm |
| 2019-03-22 | JOHN W CHILDS | Director | Buy | 107,500.00 | 9.29 | 998,675.00 | 107,500.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119023859/0001209191-19-023859-index.htm |
| 2019-03-01 | Declan Doogan | Director | Sell | 595.00 | 45.41 | 27,018.95 | 1,076,002.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm |
| 2019-02-27 | Declan Doogan | Director | Sell | 23,384.00 | 45.71 | 1,068,882.64 | 1,076,597.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm |
| 2019-12-18 | Vlad Coric | Chief Executive Officer | Buy | 10,950.00 | 10,950.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000128/0001689813-19-000128-index.htm | ||
| 2019-02-25 | Declan Doogan | Director | Sell | 13,943.00 | 45.49 | 634,267.07 | 1,099,981.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm |
| 2019-02-19 | Declan Doogan | Director | Sell | 1,400.00 | 45.51 | 63,714.00 | 1,113,924.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm |
| 2019-02-15 | Declan Doogan | Director | Sell | 678.00 | 45.42 | 30,794.76 | 1,115,324.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm |
| 2019-02-13 | Declan Doogan | Director | Sell | 6,158.00 | 44.24 | 272,429.92 | 1,116,002.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm |
| 2019-02-12 | Declan Doogan | Director | Sell | 33,842.00 | 44.32 | 1,499,877.44 | 1,122,160.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm |
| 2018-12-03 | Declan Doogan | Director | Sell | 40,000.00 | 41.95 | 1,678,000.00 | 1,156,002.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919118061265/0001209191-18-061265-index.htm |
| 2019-02-21 | JULIA P GREGORY | Director | Buy | 12,000.00 | 23.63 | 283,560.00 | 12,000.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm |
| 2019-11-22 | JULIA P GREGORY | Director | Buy | 12,000.00 | 23.63 | 283,560.00 | 12,000.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm |
| 2019-11-22 | ERIC AGUIAR | Director | Buy | 1,250.00 | 37.54 | 46,925.00 | 1,250.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm |
| 2019-12-18 | John Tilton | CCO-Rare & Neurologic Disorder | Buy | 1,250.00 | 1,250.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000133/0001689813-19-000133-index.htm | ||
| 2020-01-08 | ERIC AGUIAR | Director | Buy | 1,250.00 | 55.91 | 69,887.50 | 1,250.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm |
| 2020-01-22 | ERIC AGUIAR | Director | Sell | 150.00 | 58.86 | 8,828.60 | 1,250.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm |
| 2019-12-30 | Robert Berman | Special Projects & Med Ovrsght | Buy | 125,000.00 | 0.61 | 76,250.00 | 125,341.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm |
| 2020-06-12 | Elyse Stock | Chief Medical Officer | Sell | 15,925.00 | 64.89 | 1,033,347.77 | 13,234.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm |
| 2020-06-19 | Robert Berman | Special Projects & Med Ovrsght | Buy | 986.00 | 0.61 | 601.46 | 1,327.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm |
| 2020-06-11 | James Engelhart | Chief Financial Officer | Sell | 4,847.00 | 63.19 | 306,286.29 | 13,475.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm |
| 2020-01-22 | ERIC AGUIAR | Director | Sell | 200.00 | 58.00 | 11,599.00 | 1,400.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm |
| 2020-06-10 | James Engelhart | Chief Financial Officer | Buy | 11,453.00 | 9.29 | 106,398.37 | 15,975.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm |
| 2020-01-22 | ERIC AGUIAR | Director | Sell | 671.00 | 56.99 | 38,243.18 | 1,600.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm |
| 2020-06-18 | Robert Berman | Special Projects & Med Ovrsght | Sell | 59,914.00 | 75.25 | 4,508,822.08 | 1,741.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm |
| 2020-11-02 | WILLIAM A JR JONES | CCO-Migraine & Common Disease | Sell | 1,300.00 | 77.70 | 101,005.06 | 1,755.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm |
| 2019-02-04 | ERIC AGUIAR | Director | Buy | 7,609.00 | 20.79 | 158,191.11 | 17,609.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm |
| 2019-10-18 | Elyse Stock | Chief Medical Officer | Buy | 17,700.00 | 10.82 | 191,514.00 | 17,700.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm |
| 2020-06-11 | James Engelhart | Chief Financial Officer | Sell | 5,972.00 | 62.07 | 370,697.57 | 18,322.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm |
| 2020-06-12 | Elyse Stock | Chief Medical Officer | Sell | 11,390.00 | 65.80 | 749,497.31 | 1,844.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm |
| 2019-06-26 | Vlad Coric | Chief Executive Officer | Buy | 5,000.00 | 40.22 | 201,100.00 | 19,130.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119039193/0001209191-19-039193-index.htm |
| 2020-01-22 | ERIC AGUIAR | Director | Buy | 771.00 | 32.42 | 24,995.82 | 2,021.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm |
| 2019-11-21 | Kimberly Gentile | SVP, Clinical Operations | Buy | 21,065.00 | 0.61 | 12,849.65 | 21,065.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm |
| 2020-10-08 | Kimberly Gentile | SVP, Clinical Operations | Sell | 5,261.00 | 75.62 | 397,843.66 | 21,878.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm |
| 2020-06-12 | Elyse Stock | Chief Medical Officer | Buy | 20,716.00 | 20.79 | 430,685.64 | 22,560.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm |
| 2020-01-22 | ERIC AGUIAR | Director | Sell | 500.00 | 55.99 | 27,995.50 | 2,271.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm |
| 2019-06-27 | Robert Berman | Chief Medical Officer | Buy | 2,500.00 | 42.30 | 105,750.00 | 240,500.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119039411/0001209191-19-039411-index.htm |
| 2020-06-11 | James Engelhart | Chief Financial Officer | Buy | 19,772.00 | 9.29 | 183,681.88 | 24,294.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm |
| 2020-04-07 | JOHN W CHILDS | Director | Sell | 14,734.00 | 33.26 | 490,119.14 | 2,476,938.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm |
| 2020-08-11 | JOHN W CHILDS | Director | Buy | 2,600.00 | 60.32 | 156,823.94 | 2,479,538.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm |
| 2020-08-11 | JOHN W CHILDS | Director | Buy | 7,271.00 | 61.28 | 445,567.61 | 2,486,809.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm |
| 2020-04-07 | JOHN W CHILDS | Director | Sell | 93,268.00 | 32.92 | 3,070,130.74 | 2,491,672.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm |
| 2019-06-27 | James Engelhart | Chief Financial Officer | Buy | 2,500.00 | 43.05 | 107,625.00 | 2,500.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119039412/0001209191-19-039412-index.htm |
| 2020-08-11 | JOHN W CHILDS | Director | Buy | 15,129.00 | 61.87 | 936,093.26 | 2,501,938.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm |
| 2020-09-11 | JOHN W CHILDS | Director | Buy | 6,678.00 | 59.00 | 393,983.97 | 2,508,616.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020005986/0001562180-20-005986-index.htm |
| 2020-09-21 | JOHN W CHILDS | Director | Buy | 3,322.00 | 59.25 | 196,828.50 | 2,511,938.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006075/0001562180-20-006075-index.htm |
| 2020-10-23 | Gregory Bailey | Director | Sell | 212.00 | 79.94 | 16,948.00 | 2,545,658.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm |
| 2020-10-23 | Gregory Bailey | Director | Sell | 10,191.00 | 78.89 | 803,918.05 | 2,545,870.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm |
| 2020-10-22 | Gregory Bailey | Director | Sell | 3,100.00 | 79.88 | 247,632.03 | 2,556,061.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm |
| 2020-10-22 | Gregory Bailey | Director | Sell | 21,466.00 | 79.41 | 1,704,720.24 | 2,559,161.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm |
| 2020-10-19 | Gregory Bailey | Director | Sell | 4,554.00 | 78.98 | 359,655.34 | 2,580,627.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm |
| 2019-03-25 | Gregory Bailey | Director | Buy | 107,500.00 | 9.29 | 998,675.00 | 2,582,601.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119023860/0001209191-19-023860-index.htm |
| 2020-04-07 | JOHN W CHILDS | Director | Sell | 10,908.00 | 31.55 | 344,196.49 | 2,584,940.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm |
| 2020-10-16 | Gregory Bailey | Director | Sell | 3,748.00 | 78.88 | 295,638.12 | 2,585,181.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm |
| 2019-08-20 | Gregory Bailey | Director | Buy | 5,000.00 | 37.65 | 188,250.00 | 2,587,601.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000061/0001689813-19-000061-index.htm |
| 2020-10-12 | Gregory Bailey | Director | Sell | 6,729.00 | 78.87 | 530,740.45 | 2,588,929.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006368/0001562180-20-006368-index.htm |
| 2020-07-08 | Gregory Bailey | Director | Sell | 5,991.00 | 75.93 | 454,888.24 | 2,595,658.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm |
| 2020-04-07 | JOHN W CHILDS | Director | Sell | 81,090.00 | 30.54 | 2,476,585.91 | 2,595,848.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm |
| 2020-07-08 | Gregory Bailey | Director | Sell | 44,009.00 | 75.12 | 3,305,876.86 | 2,601,649.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm |
| 2020-06-24 | Gregory Bailey | Director | Sell | 2,395.00 | 70.24 | 168,224.80 | 2,645,658.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm |
| 2020-06-24 | Gregory Bailey | Director | Sell | 1,600.00 | 69.29 | 110,864.96 | 2,648,053.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm |
| 2020-06-23 | Gregory Bailey | Director | Sell | 835.00 | 75.18 | 62,779.31 | 2,649,653.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm |
| 2020-06-23 | Gregory Bailey | Director | Sell | 63,257.00 | 74.60 | 4,719,256.86 | 2,650,488.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm |
| 2020-04-06 | JOHN W CHILDS | Director | Sell | 5,341.00 | 31.76 | 169,626.96 | 2,676,938.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm |
| 2020-04-06 | JOHN W CHILDS | Director | Sell | 144,659.00 | 31.23 | 4,517,309.99 | 2,682,279.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm |
| 2020-06-23 | Gregory Bailey | Director | Sell | 24,084.00 | 73.72 | 1,775,368.92 | 2,713,745.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm |
| 2020-10-08 | Kimberly Gentile | SVP, Clinical Operations | Buy | 23,500.00 | 9.29 | 218,315.00 | 27,139.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm |
| 2020-06-23 | Gregory Bailey | Director | Sell | 13,467.00 | 72.70 | 979,026.66 | 2,737,829.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm |
| 2020-06-22 | Gregory Bailey | Director | Sell | 49,132.00 | 73.64 | 3,618,011.70 | 2,751,296.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm |
| 2020-06-17 | Kimberly Gentile | SVP, Clinical Operations | Buy | 24,000.00 | 5.60 | 134,400.00 | 27,639.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm |
| 2020-01-22 | ERIC AGUIAR | Director | Sell | 500.00 | 54.97 | 27,485.85 | 2,771.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm |
| 2020-06-05 | Gregory Bailey | Director | Buy | 212,500.00 | 0.61 | 129,625.00 | 2,800,101.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm |
| 2020-06-22 | Gregory Bailey | Director | Sell | 20,659.00 | 72.91 | 1,506,202.24 | 2,800,428.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm |
| 2020-06-22 | Gregory Bailey | Director | Sell | 10,540.00 | 72.01 | 758,961.16 | 2,821,087.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm |
| 2020-06-19 | Gregory Bailey | Director | Sell | 428.00 | 75.22 | 32,193.39 | 2,831,627.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm |
| 2020-06-19 | Gregory Bailey | Director | Sell | 22,584.00 | 73.78 | 1,666,267.85 | 2,832,055.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm |
| 2020-06-19 | Gregory Bailey | Director | Sell | 12,157.00 | 72.93 | 886,618.52 | 2,854,639.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm |
| 2020-06-19 | Gregory Bailey | Director | Sell | 21,798.00 | 71.98 | 1,568,935.03 | 2,866,796.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm |
| 2020-06-19 | Gregory Bailey | Director | Sell | 58,238.00 | 70.91 | 4,129,854.59 | 2,888,594.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm |
| 2020-06-12 | Elyse Stock | Chief Medical Officer | Sell | 5,300.00 | 64.05 | 339,448.04 | 29,159.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm |
| 2020-06-19 | Gregory Bailey | Director | Sell | 26,814.00 | 70.10 | 1,879,792.79 | 2,946,832.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm |
| 2020-06-05 | Gregory Bailey | Director | Buy | 150,000.00 | 5.60 | 840,000.00 | 2,950,101.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm |
| 2020-06-10 | James Engelhart | Chief Financial Officer | Sell | 28,821.00 | 66.66 | 1,921,135.81 | 29,654.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm |
| 2020-06-19 | Gregory Bailey | Director | Sell | 22,012.00 | 69.01 | 1,519,094.35 | 2,973,646.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm |
| 2020-06-05 | Gregory Bailey | Director | Buy | 37,700.00 | 9.29 | 350,233.00 | 2,987,801.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm |
| 2019-12-18 | WILLIAM A JR JONES | CCO-Migraine & Common Disease | Buy | 3,000.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000132/0001689813-19-000132-index.htm | ||
| 2020-01-09 | ERIC AGUIAR | Director | Buy | 30,000.00 | 9.29 | 278,700.00 | 30,000.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm |
| 2020-06-05 | Gregory Bailey | Director | Buy | 20,000.00 | 10.82 | 216,400.00 | 3,007,801.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm |
| 2020-06-05 | Gregory Bailey | Director | Buy | 18,000.00 | 28.76 | 517,680.00 | 3,025,801.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm |
| 2020-01-09 | Kimberly Gentile | SVP, Clinical Operations | Buy | 1,000.00 | 37.54 | 37,540.00 | 3,049.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm |
| 2020-11-02 | WILLIAM A JR JONES | CCO-Migraine & Common Disease | Sell | 4,010.00 | 77.01 | 308,799.27 | 3,055.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm |
| 2020-07-08 | Robert Berman | Special Projects & Med Ovrsght | Sell | 55,626.00 | 75.25 | 4,185,745.25 | 3,119.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm |
| 2020-06-10 | John Tilton | Chief Commercial Officer | Sell | 21,364.00 | 66.70 | 1,425,036.48 | 31,406.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm |
| 2020-11-02 | WILLIAM A JR JONES | CCO-Migraine & Common Disease | Buy | 30,000.00 | 50.72 | 1,521,600.00 | 31,755.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm |
| 2020-06-10 | John Tilton | Chief Commercial Officer | Sell | 5,331.00 | 68.57 | 365,528.01 | 3,237.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm |
| 2020-01-22 | ERIC AGUIAR | Director | Buy | 1,250.00 | 37.54 | 46,925.00 | 3,271.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm |
| 2020-06-10 | James Engelhart | Chief Financial Officer | Buy | 17,500.00 | 0.61 | 10,675.00 | 33,475.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm |
| 2019-12-18 | Elyse Stock | Chief Medical Officer | Buy | 3,375.00 | 3,375.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000134/0001689813-19-000134-index.htm | ||
| 2019-12-30 | Robert Berman | Special Projects & Med Ovrsght | Sell | 300.00 | 55.97 | 16,791.00 | 341.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm |
| 2020-06-18 | Robert Berman | Special Projects & Med Ovrsght | Sell | 1,400.00 | 76.05 | 106,467.48 | 341.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm |
| 2020-06-19 | Robert Berman | Special Projects & Med Ovrsght | Sell | 986.00 | 75.07 | 74,015.96 | 341.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm |
| 2020-06-23 | Robert Berman | Special Projects & Med Ovrsght | Sell | 4,296.00 | 75.05 | 322,431.12 | 341.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm |
| 2020-07-08 | Robert Berman | Special Projects & Med Ovrsght | Sell | 2,778.00 | 75.29 | 209,144.51 | 341.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm |
| 2020-06-12 | Elyse Stock | Chief Medical Officer | Sell | 4,351.00 | 63.02 | 274,208.72 | 34,459.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm |
| 2019-12-16 | ERIC AGUIAR | Director | Buy | 3,537.00 | 20.79 | 73,534.23 | 3,537.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm |
| 2020-01-09 | Kimberly Gentile | SVP, Clinical Operations | Buy | 590.00 | 20.79 | 12,266.10 | 3,639.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm |
| 2020-06-08 | Kimberly Gentile | SVP, Clinical Operations | Sell | 600.00 | 70.05 | 42,027.48 | 3,639.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm |
| 2020-06-17 | Kimberly Gentile | SVP, Clinical Operations | Sell | 24,000.00 | 70.20 | 1,684,869.60 | 3,639.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm |
| 2020-10-08 | Kimberly Gentile | SVP, Clinical Operations | Sell | 2,458.00 | 77.42 | 190,300.08 | 3,639.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm |
| 2020-06-18 | Robert Berman | Special Projects & Med Ovrsght | Buy | 36,314.00 | 0.61 | 22,151.54 | 36,655.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm |
| 2019-02-27 | Declan Doogan | Director | Sell | 1,900.00 | 45.86 | 87,134.00 | 373,913.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm |
| 2019-12-18 | Kimberly Gentile | SVP, Clinical Operations | Buy | 3,750.00 | 3,750.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000131/0001689813-19-000131-index.htm | ||
| 2019-02-27 | Declan Doogan | Director | Sell | 18,270.00 | 45.25 | 826,717.50 | 375,813.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm |
| 2020-06-12 | Elyse Stock | Chief Medical Officer | Buy | 16,250.00 | 32.42 | 526,825.00 | 38,810.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm |
| 2019-11-20 | Kimberly Gentile | SVP, Clinical Operations | Buy | 3,935.00 | 0.61 | 2,400.35 | 3,935.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm |
| 2019-02-27 | Declan Doogan | Director | Sell | 6,875.00 | 44.17 | 303,668.75 | 394,083.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm |
| 2019-02-26 | Declan Doogan | Director | Sell | 100.00 | 44.81 | 4,481.00 | 400,958.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm |
| 2019-02-26 | Declan Doogan | Director | Sell | 20,796.00 | 44.31 | 921,470.76 | 401,058.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm |
| 2020-06-17 | Kimberly Gentile | SVP, Clinical Operations | Buy | 400.00 | 5.60 | 2,240.00 | 4,039.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004603/0001562180-20-004603-index.htm |
| 2019-12-09 | ERIC AGUIAR | Director | Buy | 4,072.00 | 20.79 | 84,656.88 | 4,072.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm |
| 2019-12-30 | Robert Berman | Special Projects & Med Ovrsght | Sell | 53,762.00 | 53.43 | 2,872,449.90 | 4,129.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm |
| 2019-02-25 | Declan Doogan | Director | Sell | 100.00 | 45.74 | 4,574.00 | 421,854.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm |
| 2019-02-25 | Declan Doogan | Director | Sell | 20,334.00 | 45.25 | 920,113.50 | 421,954.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm |
| 2020-06-08 | Kimberly Gentile | SVP, Clinical Operations | Buy | 600.00 | 5.60 | 3,360.00 | 4,239.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm |
| 2019-03-14 | Vlad Coric | Chief Executive Officer | Sell | 15,783.00 | 50.03 | 789,623.49 | 440,000.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm |
| 2019-02-22 | Declan Doogan | Director | Sell | 16,050.00 | 44.97 | 721,768.50 | 442,288.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm |
| 2020-06-10 | James Engelhart | Chief Financial Officer | Sell | 300.00 | 68.07 | 20,420.01 | 4,522.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm |
| 2020-06-11 | James Engelhart | Chief Financial Officer | Sell | 2,452.00 | 64.85 | 159,015.39 | 4,522.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm |
| 2019-03-13 | Vlad Coric | Chief Executive Officer | Sell | 8,262.00 | 50.02 | 413,265.24 | 455,783.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm |
| 2019-02-22 | Declan Doogan | Director | Sell | 5,575.00 | 44.11 | 245,913.25 | 458,338.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm |
| 2020-06-23 | Robert Berman | Special Projects & Med Ovrsght | Buy | 4,296.00 | 0.61 | 2,620.56 | 4,637.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm |
| 2019-03-12 | Vlad Coric | Chief Executive Officer | Sell | 25,955.00 | 50.15 | 1,301,643.25 | 464,045.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm |
| 2019-03-14 | Vlad Coric | Chief Executive Officer | Sell | 16,110.00 | 50.02 | 805,822.20 | 475,000.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm |
| 2020-06-10 | James Engelhart | Chief Financial Officer | Sell | 24,832.00 | 67.53 | 1,676,989.39 | 4,822.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm |
| 2019-03-13 | Vlad Coric | Chief Executive Officer | Sell | 7,883.00 | 50.02 | 394,307.66 | 491,110.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm |
| 2019-03-12 | Vlad Coric | Chief Executive Officer | Sell | 26,007.00 | 50.15 | 1,304,251.05 | 498,993.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm |
| 2020-06-10 | John Tilton | Chief Commercial Officer | Buy | 52,000.00 | 9.29 | 483,080.00 | 52,770.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm |
| 2019-12-30 | Robert Berman | Special Projects & Med Ovrsght | Sell | 67,450.00 | 52.95 | 3,571,349.35 | 57,891.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm |
| 2020-06-10 | James Engelhart | Chief Financial Officer | Buy | 25,000.00 | 5.60 | 140,000.00 | 58,475.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm |
| 2020-07-08 | Robert Berman | Special Projects & Med Ovrsght | Buy | 58,404.00 | 0.61 | 35,626.44 | 58,745.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm |
| 2020-10-08 | Kimberly Gentile | SVP, Clinical Operations | Sell | 15,781.00 | 76.42 | 1,205,938.26 | 6,097.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm |
| 2020-06-18 | Robert Berman | Special Projects & Med Ovrsght | Buy | 25,000.00 | 5.60 | 140,000.00 | 61,655.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm |
| 2019-12-18 | James Engelhart | Chief Financial Officer | Buy | 3,700.00 | 6,200.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000129/0001689813-19-000129-index.htm | ||
| 2019-12-18 | Robert Berman | Special Projects & Med Ovrsght | Buy | 625.00 | 625.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000136/0001689813-19-000136-index.htm | ||
| 2020-06-16 | Declan Doogan | Director | Sell | 300.00 | 69.42 | 20,825.01 | 626,002.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm |
| 2020-06-16 | Declan Doogan | Director | Sell | 25,208.00 | 68.73 | 1,732,457.61 | 626,302.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm |
| 2019-12-30 | Robert Berman | Special Projects & Med Ovrsght | Sell | 3,488.00 | 54.89 | 191,462.25 | 641.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm |
| 2020-06-16 | Declan Doogan | Director | Sell | 31,920.00 | 67.90 | 2,167,514.83 | 651,510.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm |
| 2019-11-20 | ERIC AGUIAR | Director | Buy | 6,729.00 | 32.42 | 218,154.18 | 6,729.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm |
| 2020-06-16 | Declan Doogan | Director | Sell | 2,572.00 | 66.94 | 172,161.71 | 683,430.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm |
| 2020-06-15 | Declan Doogan | Director | Sell | 15,797.00 | 68.10 | 1,075,800.98 | 686,002.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm |
| 2020-06-11 | James Engelhart | Chief Financial Officer | Sell | 6,501.00 | 64.31 | 418,057.86 | 6,974.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm |
| 2019-12-18 | Charles Conway | Chief Scientific Officer | Buy | 3,000.00 | 7,000.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000135/0001689813-19-000135-index.htm | ||
| 2020-06-15 | Declan Doogan | Director | Sell | 18,703.00 | 67.51 | 1,262,557.24 | 701,799.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm |
| 2020-11-02 | WILLIAM A JR JONES | CCO-Migraine & Common Disease | Sell | 24,690.00 | 76.02 | 1,876,872.08 | 7,065.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm |
| 2020-06-15 | Declan Doogan | Director | Sell | 34,336.00 | 66.05 | 2,267,872.20 | 720,502.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm |
| 2020-06-15 | Declan Doogan | Director | Sell | 11,164.00 | 65.62 | 732,560.47 | 754,838.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm |
| 2020-06-12 | Declan Doogan | Director | Sell | 25,914.00 | 65.78 | 1,704,749.90 | 766,002.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm |
| 2020-06-10 | John Tilton | Chief Commercial Officer | Sell | 2,467.00 | 69.40 | 171,201.91 | 770.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm |
| 2020-06-12 | Declan Doogan | Director | Sell | 28,086.00 | 64.79 | 1,819,683.51 | 791,916.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm |
| 2019-10-15 | Elyse Stock | Chief Medical Officer | Buy | 800.00 | 10.82 | 8,656.00 | 800.00 | https://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm |
| 2020-06-12 | Declan Doogan | Director | Sell | 18,400.00 | 63.90 | 1,175,767.36 | 820,002.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm |
| 2020-06-12 | Declan Doogan | Director | Sell | 7,600.00 | 62.93 | 478,252.04 | 838,402.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm |
| 2020-06-11 | Declan Doogan | Director | Sell | 25,039.00 | 64.57 | 1,616,873.39 | 846,002.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm |
| 2020-06-10 | John Tilton | Chief Commercial Officer | Sell | 22,838.00 | 67.53 | 1,542,234.15 | 8,568.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm |
| 2020-06-11 | Declan Doogan | Director | Sell | 18,474.00 | 63.79 | 1,178,530.36 | 871,041.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm |
| 2020-06-11 | Declan Doogan | Director | Sell | 20,043.00 | 62.78 | 1,258,207.34 | 889,515.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm |
| 2020-06-11 | Declan Doogan | Director | Sell | 16,444.00 | 61.97 | 1,018,988.64 | 909,558.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm |
| 2019-04-16 | Declan Doogan | Director | Sell | 50,000.00 | 61.92 | 3,096,000.00 | 926,002.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm |
| 2020-01-08 | Elyse Stock | Chief Medical Officer | Buy | 937.00 | 55.91 | 52,387.67 | 937.00 | https://www.sec.gov/Archives/edgar/data/1689813/000156218020000346/0001562180-20-000346-index.htm |
| 2019-04-12 | Declan Doogan | Director | Sell | 38,825.00 | 53.92 | 2,093,444.00 | 976,002.00 | https://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm |